Key Points
- Director Daniel Kaye sold 532 CME Group shares at an average price of $304.17, totaling about $161,818. He retained 4,313 shares after the sale.
- CME Group’s latest quarterly results beat estimates, with EPS of $3.02 and revenue of $1.74 billion; revenue grew 10.6% year over year.
- The company announced a quarterly dividend of $1.30 per share, equivalent to $5.20 annually and a 1.7% yield.
CME Group Inc. (NASDAQ:CME - Get Free Report) Director Daniel Kaye sold 532 shares of CME Group stock in a transaction on Monday, November 9th. The shares were sold at an average price of $304.17, for a total value of $161,818.44. Following the transaction, the director owned 4,313 shares in the company, valued at $1,311,885.21. This trade represents a 10.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
CME Group Stock Performance
Shares of CME opened at $309.09 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a 50-day simple moving average of $283.95 and a two-hundred day simple moving average of $281.05. The stock has a market cap of $110.63 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 3.72 and a beta of 0.15. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. During the same quarter last year, the company earned $2.68 earnings per share. The business's revenue for the quarter was up 10.6% compared to the same quarter last year. On average, analysts expect that CME Group Inc. will post 12.34 EPS for the current year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be issued a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Friday, December 11th. CME Group's dividend payout ratio is currently 42.66%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. First Community Trust NA purchased a new stake in CME Group during the 3rd quarter valued at approximately $26,000. North Point Portfolio Managers Corp OH purchased a new position in shares of CME Group in the third quarter worth $26,000. Main Street Group LTD purchased a new position in shares of CME Group in the first quarter worth $32,000. Compass Financial Management LLC lifted its holdings in shares of CME Group by 471.4% in the third quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider's stock worth $31,000 after buying an additional 99 shares in the last quarter. Finally, Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of CME Group during the second quarter worth $28,000. 87.75% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
CME has been the topic of a number of recent analyst reports. Morgan Stanley raised their target price on shares of CME Group from $337.00 to $359.00 and gave the stock an "overweight" rating in a research note on Thursday, October 22nd. Barclays upped their price target on shares of CME Group from $281.00 to $321.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 22nd. Bank of America upped their price target on shares of CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a research report on Thursday, July 23rd. UBS Group increased their price objective on shares of CME Group from $270.00 to $310.00 and gave the stock a "neutral" rating in a research note on Thursday, October 22nd. Finally, Wall Street Zen upgraded shares of CME Group from a "sell" rating to a "hold" rating in a research report on Saturday, October 31st. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $314.44.
Get Our Latest Research Report on CME Group
About CME Group
(
Get Free Report)
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
